Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. The company is headquartered in Secunderabad, Telangana. The firm also has active loan licenses and contract manufacturing tie-ups with multinational companies for API’s and drug intermediates. The company serves the global life science industry. Its API products offering includes Ciprofloxacin HCl USP/EP/BP/IP, Ciprofloxacin (Base) USP/EP/BP/IP, Ciprofloxacin Lactate IH, Ciprofloxacin Betaine IH, Mefenamic Acid USP/EP/BP/IP, Enrofloxacin USP/EP/BP/IP and Elthambutoal HCI USP/BP/IP. Its intermediates include A D Lactone (for Spironolactone) and 6 Mercaptopurine (for Azathioprine). The firm's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.